Haptoglobin phenotypes in systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 26, Issue 6, 2008, Pages 1162-

  Giordano, Nicola ^a   Guerranti, R ^a   Bertocci, E ^a   Papakostas, P ^a   Rollo, F ^a   Figura, N ^a   Leoncini, R ^a   Pagani, R ^a   Nuti, R ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CENTROMERE ANTIBODY; DNA TOPOISOMERASE; HAPTOGLOBIN; RNA POLYMERASE;

ADULT; BLOOD SAMPLING; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FIBROSING ALVEOLITIS; HUMAN; IMMUNOBLOTTING; LETTER; MALE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SYNDROME CREST; SYSTEMIC SCLEROSIS;

ADULT; FEMALE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; SCLERODERMA, SYSTEMIC;

EID: 59149106054     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. LANGLOIS MR, DELANGHE JR: Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42: 1589-600.
2. CARTER K, WORWOOD M: Haptoglobin: A review of the major allele frequencies worldwide and their association diseases. Int J Lab Hematol 2007; 29: 92-110.
3. BOTTINI N, GLORIA-BOTTINI F, AMANTE A, SACUCCI P, BOTTINI E: Genetic polymorphism and TH1/TH2 orientation. Int Arch Allergy Immunol 2005; 138: 328-33.
4. GUETTA J, STRAUSS M, LEVY NS, FAHOUM L, LEVY AP: Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis 2007; 191: 48-53.
5. ATZENI F, BARDONI A, CUTOLO M et al.: Localized and systemic forms of scleroderma in adults and children. Clin Exp Rheumatol 2006; 24 (Suppl. 40: S36-45.
6. MAVALIA C, SCALETTI C, ROMAGNANI P et al.: Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathos 1997; 151: 1751-8.
7. OLIVER SJ: The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide. Curr Rheumatol Rep 2000; 2: 486-91.
8. MATSUSHITA T, HASEGAWA M, HAMAGUCHI Y, TAKEHARA K, SATO S: Longitudinal analysis of serum cytokines concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol 2006; 33: 275-84.
9. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
10. PAVÓN EJ, MUÑOZ P, LARIO A et al.: Proteomic analysis of plasma from patients with systemic lupus erythematosus: Increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms. Proteomics 2006; (Suppl. 1): S282-92.